Ignite Creation Date:
2024-05-05 @ 12:09 PM
Last Modification Date:
2024-10-26 @ 9:21 AM
Study NCT ID:
NCT00267657
Status:
UNKNOWN
Last Update Posted:
2017-01-11
First Post:
2005-12-20
Brief Title:
A Phase 1 Parallel-Group Double-Blind Placebo-Controlled Cardiovascular and Behavioral Study Assessing Interactions Between Single Doses of Oral Reserpine and Intravenous Methamphetamine - 1
Sponsor:
National Institute on Drug Abuse NIDA
Organization:
National Institute on Drug Abuse NIDA
Organization Data
Organization:
National Institute on Drug Abuse NIDA
Class:
NIH
Study ID:
NIDA-CPU-0006-1
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
National Institute on Drug Abuse NIDA
Lead Sponsor Class:
NIH
Responsible Party:
None
Responsible Party Title:
None
Responsible Party Type:
None
Responsible Party Affiliation:
None
Old Name:
None
Old Organization:
None